Abbott Laboratories (NYSE:ABT) Upgraded at StockNews.com
StockNews.com upgraded shares of Abbott Laboratories (NYSE:ABT – Free Report) from a buy rating to a strong-buy rating in a ...
Dallas Morning News24d
Abbott threatens Texas A&M president over DEI controversy
Abbott’s threat to A&M comes as Texas kicks ... a conference for those underrepresented in business schools and the corporate world. Rufo also posted an image from the conference’s website ...
Abbott India gains 10% in 2 days after posting healthy Q3 show; Details
The company's Q3 profir increased 16 per cent year-on-year (Y-o-Y) to Rs 360.78 crore as compared to Rs 310.98 crore ...
Crain's Chicago Business1mon
Why Abbott and Dexcom buried the hatchet in their glucose monitor patent fight
Abbott Laboratories and Decom will concentrate on competing in the huge market of potential continuous glucose monitor technology and put any patent disputes behind them for 10 years. North ...
Abbott Laboratories (ABT) Gets a Buy from RBC Capital
In a report released on January 17, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Abbott Laboratories (ABT – Research ...